Tunable Emissive Ir(III) Benzimidazole-quinoline Hybrids as Promising Theranostic Lead Compounds.

Journal Information

Full Title: ChemMedChem

Abbreviation: ChemMedChem

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Pharmacology

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare no conflict of interest."

Evidence found in paper:

"Authors thank the Agencia Estatal de Investigación, projects PID2019‐104379RB‐C21/AEI/10.13039/501100011033, RTI2018‐097836‐J‐I00/MCIN/AEI/10.13039/501100011033/FEDER, RYC2018‐025872‐I (funded by MCIN/AEI/10.13039/501100011033 and by “ESF Investing in your future”), RED2018‐102471‐T/MCIN/AEI/10.13039/501100011033, and Gobierno de Aragón‐Fondo Social Europeo (E07_20R) for financial support. M. R. thanks the Gobierno de Aragón for a predoctoral fellowship."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025